Bio-Rad Laboratories, Inc. (NYSE:BIO)

CAPS Rating: 5 out of 5

The Company manufactures and supplies the life science research, healthcare, analytical chemistry, and other markets with products and systems used to separate chemical and biological materials, and to identify analyze and purify their components.

Recs

0
Player Avatar nau99 (27.63) Submitted: 3/10/2007 9:16:36 PM : Underperform Start Price: $69.14 BIO Score: -28.51

Cut in earnings leaves the stock worth $50-60. This one still has further to fall.

Featured Broker Partners


Advertisement